Scarica l'app Stockscreener
1.81
2.16%
-0.04
Dopo l'orario di chiusura:
1.83
0.02
+1.10%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BMEA Giù?
Forum
Previsione
Precedente Chiudi:
$1.85
Aprire:
$1.86
Volume 24 ore:
658.64K
Relative Volume:
0.29
Capitalizzazione di mercato:
$68.01M
Reddito:
-
Utile/perdita netta:
$-144.01M
Rapporto P/E:
-0.4514
EPS:
-4.01
Flusso di cassa netto:
$-113.02M
1 W Prestazione:
-3.72%
1M Prestazione:
-3.72%
6M Prestazione:
-58.96%
1 anno Prestazione:
-66.79%
Intervallo 1D:
$1.785
$1.90
Intervallo di 1 settimana:
$1.785
$1.9098
Portata 52W:
$1.2905
$13.07
Biomea Fusion Inc Stock (BMEA) Company Profile
Nome
Biomea Fusion Inc
Settore
Industria
Telefono
(650) 980-9099
Indirizzo
900 MIDDLEFIELD ROAD, REDWOOD CITY
Confronta BMEA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BMEA
Biomea Fusion Inc
|
1.81 | 103.78M | 0 | -144.01M | -113.02M | -4.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Biomea Fusion Inc Stock (BMEA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-03 | Ripresa | Piper Sandler | Overweight |
| 2024-10-09 | Iniziato | Edward Jones | Buy |
| 2024-09-27 | Aggiornamento | Rodman & Renshaw | Neutral → Buy |
| 2024-09-27 | Aggiornamento | Truist | Hold → Buy |
| 2024-08-29 | Iniziato | CapitalOne | Overweight |
| 2024-06-11 | Downgrade | Truist | Buy → Hold |
| 2024-06-07 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-04-02 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-02-06 | Iniziato | Truist | Buy |
| 2023-07-27 | Iniziato | Scotiabank | Sector Outperform |
| 2023-06-26 | Downgrade | Jefferies | Buy → Hold |
| 2023-05-12 | Iniziato | Barclays | Overweight |
| 2023-03-29 | Reiterato | Oppenheimer | Outperform |
| 2023-03-28 | Reiterato | H.C. Wainwright | Buy |
| 2023-02-24 | Iniziato | Citigroup | Buy |
| 2022-06-02 | Ripresa | H.C. Wainwright | Buy |
| 2022-01-12 | Iniziato | H.C. Wainwright | Buy |
| 2021-12-17 | Iniziato | Oppenheimer | Outperform |
| 2021-05-11 | Iniziato | JP Morgan | Overweight |
| 2021-05-11 | Iniziato | Jefferies | Buy |
| 2021-05-11 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Biomea Fusion Inc Borsa (BMEA) Ultime notizie
Biomea Fusion Appoints Julianne Averill to its Board of Directors - The Manila Times
Biomea Fusion appoints Julianne Averill to board of directors - Investing.com Australia
Diabetes Drug Developer Biomea Fusion Strengthens Board with Finance Veteran Julianne Averill - Stock Titan
What drives Biomea Fusion Inc. stock priceRapid-fire capital growth - Autocar Professional
Biomea Fusion Inc. Stock Analysis and ForecastExplosive earning power - jammulinksnews.com
What analysts say about Biomea Fusion Inc. stockBreakthrough profit margins - jammulinksnews.com
Is Biomea Fusion Inc. a good long term investmentBreakthrough capital growth - jammulinksnews.com
Citigroup Lowers Biomea Fusion Price Target to $9.00 Amid "Buy" Rating - AInvest
Citigroup Has Lowered Expectations for Biomea Fusion (NASDAQ:BMEA) Stock Price - Defense World
What makes Biomea Fusion Inc. stock price move sharplyFree Best Performing Stock Alerts - Newser
How Biomea Fusion Inc. stock performs during market volatilityInsider Level Guidance - Newser
Why Biomea Fusion Inc. stock attracts strong analyst attentionFree Market Analysis Group - Newser
While institutions invested in Biomea Fusion, Inc. (NASDAQ:BMEA) benefited from last week's 15% gain, retail investors stood to gain the most - Yahoo Finance
Want to make yourself less appealing to mosquitoes? Our quiz has surprising ideas - Alaska Public Media
Biomea Fusion, Inc. (NASDAQ:BMEA) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Biomea Fusion’s BMF-219 Study Update: Implications for Investors - TipRanks
Biomea Fusion’s BMF-219 Study: A Potential Game-Changer for Type 2 Diabetes - TipRanks
Oppenheimer & Co. Inc. Buys 78,579 Shares of Biomea Fusion, Inc. (NASDAQ:BMEA) - Defense World
Biomea Fusion’s Phase 2 Trial: A New Hope for Type 1 Diabetes Treatment - TipRanks
Biomea Fusion, Inc.(NasdaqGS: BMEA) dropped from Russell 2000 Index - MarketScreener
Biomea Fusion, Inc.(NasdaqGS: BMEA) added to Russell Microcap Value Index - MarketScreener
HC Wainwright Predicts Stronger Earnings for Biomea Fusion - Defense World
Exchange Traded Concepts LLC Grows Stock Holdings in Biomea Fusion, Inc. (NASDAQ:BMEA) - Defense World
Biomea Fusion (BMEA) Receives Continued Buy Rating from Analyst - GuruFocus
Biomea Fusion stock price target cut to $4 from $18 at H.C. Wainwright By Investing.com - Investing.com South Africa
Biomea Fusion Presents New Preclinical and Clinical Data on Icovamenib at the 85th Scientific Sessions of the American Diabetes Association (ADA) - The Manila Times
Biomea Fusion Closes $37.1M Stock Offering - TipRanks
Biomea Fusion stock falls after announcing public offering - Investing.com Australia
Market Today: Safran's Asset Sale and Biomea Fusion's Stock Offering - GuruFocus
Crude Oil Moves Higher; US Weekly Jobless Claims Decline - Benzinga
Top Midday Decliners - MarketScreener
Biomea Fusion stock falls after announcing public offering By Investing.com - Investing.com South Africa
Biomea Fusion (BMEA) Reports Promising Preclinical Results for W - GuruFocus
Bitdeer, Biomea Fusion, Circle Internet - TradingView
Biomea Fusion (BMEA) Reports Promising Preclinical Results for Weight Loss Study | BMEA Stock News - GuruFocus
Biomea Fusion Reports Preclinical Data for BMF-650, a - GlobeNewswire
Biomea Fusion (BMEA) Receives Reaffirmed Buy Rating by D. Boral Capital | BMEA Stock News - GuruFocus
Biomea Fusion surges 76% following InvestingPro’s April Fair Value alert By Investing.com - Investing.com India
Biomea Fusion Reports Preclinical Data for BMF-650, a Next-Generation Oral GLP-1 Receptor Agonist Candidate, Demonstrating Robust Weight Loss and Appetite Suppression in Obese Non-Human Primates - Yahoo Finance
US Stocks Likely To Open Higher Despite Trump's 'Unconditional Surrender' Call: All Eyes On Powell As Experts Predict Inflation Will Limit Fed's Rate Cut Capacity - Benzinga
Why Beyond Air Shares Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket - Benzinga
Biomea Fusion tumbles on deep-discounted $40 mln equity raise - TradingView
Biomea Fusion Prices $40 Million Offering of Securities - marketscreener.com
Biomea Fusion (BMEA) Launches Public Offering with Warrants | BM - GuruFocus
Biomea Fusion (BMEA) Launches $40M Public Offering, Shares Drop - GuruFocus
Biomea Fusion Inc Azioni (BMEA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):